Skip to content

Cancer Survivors Acute Exercise Response 1

Immune and Skeletal Muscle Response to an Exercise Session in Cancer Survivors

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03903848
Enrollment
18
Registered
2019-04-04
Start date
2019-07-01
Completion date
2023-12-31
Last updated
2019-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms Malignant

Brief summary

The aims of this study examine the immune system, muscle metabolism, and autonomic nervous system response to an acute bout of exercise. Cancer survivors will participate in an acute bout of exercise. Blood samples will be collected before the exercise bout and at two time points after the exercise bout to assess the proposed variables.

Interventions

OTHERExercise

Single session of treadmill walking and resistance exercise

Sponsors

University of Houston
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Between the ages of 40-70 years * At least two years past detectible cancer (two years disease-free survival) * Have received chemotherapy and/or radiation as part of their cancer treatment * All cancers were of the organs/non-blood producing tissues (not blood/hematologic cancers) and while they were an adult (no history of pediatric cancer) * Meeting ACSM-AHA guidelines for exercise (150 minutes per week of cardiorespiratory fitness type exercises and \ two days per week of resistance training), as confirmed by a combination of a physical activity questionnaire and a cardiorespiratory fitness classification of good or higher (age and sex matched) * A BMI between 20-33 kg·m-2 * Able to speak and read English

Exclusion criteria

Participants may not: * Have any contraindications to moderate to vigorous exercise * Have any recent illness or have been instructed not to exercise by a healthcare provider * Participants may not have range of motion restrictions that would prevent them from participating in aerobic or resistance training with proper form (they must be ambulatory) * Be taking medications (prescription or over the counter) known to influence immune function (including daily NSAID's and beta blockers), cholesterol-lowering medications (statins), drugs that increase bone mass (bisphosphonates), or steroids. * Have known cardiovascular, respiratory, metabolic, or renal disease, with the exception of controlled hypertension (as defined by resting BP below 140/90) and/or controlled asthma (self-reported). * Be pregnant * Be unable to complete all visits (i.e. must not be planning to leave the Houston area long-term before concluding their participation in the study) * Fall outside of a BMI range of (20 - 33) * Consume alcohol or recreational drugs for 24h prior to visits * Participants must not have scheduling conflicts that would prevent them from reporting to the laboratory of integrated physiology 2-3 times over the course of the study

Design outcomes

Primary

MeasureTime frameDescription
Exercise-induced response of circulating monocytesPre-exercise, change from pre-exercise to immediately post-exercise, change from pre-exercise to 1hr post-exercise, change from immediately post-exercise to 1hr post-exerciseCirculating serum monocyte phenotype before and after one exercise session
Exercise-induced response of circulating T cellsPre-exercise, change from pre-exercise to immediately post-exercise, change from pre-exercise to 1hr post-exercise, change from immediately post-exercise to 1hr post-exerciseCirculating serum T cells phenotype before and after one exercise session
Exercise-induced response of circulating FollistatinPre-exercise, change from pre-exercise to immediately post-exercise, change from pre-exercise to 1hr post-exercise, change from immediately post-exercise to 1hr post-exerciseCirculating serum follistatin before and after one exercise session
Exercise-induced response of circulating GDF-15Pre-exercise, change from pre-exercise to immediately post-exercise, change from pre-exercise to 1hr post-exercise, change from immediately post-exercise to 1hr post-exerciseCirculating serum growth differentiation factor 15 before and after one exercise session

Secondary

MeasureTime frameDescription
Body compositionbefore exerciseRelative body composition, as calculated from a DEXA scan. Measurement will be used as a descriptive variable and potential covariant
Body weightbefore exerciseAbsolute body weight as measured with an eye level beam. Measurement will be used as a descriptive variable and potential covariant

Contacts

Primary ContactMelissa Markofski, PhD
mmarkofski@uh.edu7137436658

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026